Doxycycline Suppresses Vasculogenic Mimicry in Human Pterygium Fibroblasts.

He, Meng-Xuan; Zhang, Jun-Fang; Yang, Ling; Qin, Bai; Gu, Hong-Wei; Tang, Qiu-Yang; Guan, Huai-Jin; Shi, Hai-Hong

He, Meng-Xuan; Zhang, Jun-Fang; Yang, Ling; Qin, Bai; Gu, Hong-Wei; Tang, Qiu-Yang; Guan, Huai-Jin; Shi, Hai-Hong.

Afiliación

He MX; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Zhang JF; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Yang L; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Qin B; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Gu HW; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Tang QY; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Guan HJ; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.
Shi HH; Eye Institute, Affiliated Hospital of Nantong University, Nantong, China.

Curr Eye Res ; 47(10): 1381-1388, 2022 10.

Article en En | MEDLINE | ID: mdl-35923150

Asunto(s)

Metaloproteinasa 2 de la Matriz; Pterigion; Línea Celular Tumoral; Conjuntiva/anomalías; Doxiciclina/farmacología; Fibroblastos/metabolismo; Humanos; Metaloproteinasa 2 de la Matriz/metabolismo; Metaloproteinasa 9 de la Matriz/metabolismo; Neovascularización Patológica/metabolismo; Ácido Peryódico; Pterigion/tratamiento farmacológico; Factor A de Crecimiento Endotelial Vascular/metabolismo

Palabras clave

Doxycycline; pterygium; vasculogenic mimicry (VM)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Pterigion / Metaloproteinasa 2 de la Matriz Límite: Humans Idioma: En Revista: Curr Eye Res Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google